Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 16;313(2-3):145-150.
doi: 10.1016/j.tox.2012.11.012. Epub 2012 Dec 3.

Exposure profiling of reactive compounds in complex mixtures

Shilpi Goel #  1 , Julie A Evans-Johnson #  1 , Nadia I Georgieva  1 , Gunnar Boysen  1
Affiliations

Exposure profiling of reactive compounds in complex mixtures

Shilpi Goel et al. Toxicology. .

Abstract

Humans are constantly exposed to mixtures, such as tobacco smoke, exhaust from diesel, gasoline or new bio-fuels, containing several 1000 compounds, including many known human carcinogens. Covalent binding of reactive compounds or their metabolites to DNA and formation of stable adducts is believed to be the causal link between exposure and carcinogenesis. DNA and protein adducts are well established biomarkers for the internal dose of reactive compounds or their metabolites and are an integral part of science-based risk assessment. However, technical limitations have prevented comprehensive detection of a broad spectrum of adducts simultaneously. Therefore, most studies have focused on measurement of abundant individual adducts. These studies have produced valuable insight into the metabolism of individual carcinogens, but they are insufficient for risk assessment of exposure to complex mixtures. To overcome this limitation, we present herein proof-of-principle for comprehensive exposure assessment, using N-terminal valine adduct profiles as a biomarker. The reported method is based on our previously established immunoaffinity liquid chromatography-tandem mass spectrometry (LC-MS/MS) method with modification to enrich all N-terminal valine alkylated peptides. The method was evaluated using alkylated peptide standards and globin reacted in vitro with alkylating agents (1,2-epoxy-3-butene, 1,2:3,4-diepoxybutane, propylene oxide, styrene oxide, N-ethyl-N-nitrosourea and methyl methanesulfonate), known to form N-terminal valine adducts. To demonstrate proof-of-principle, the method was successfully applied to globin from mice treated with four model compounds. The results suggest that this novel approach might be suitable for in vivo biomonitoring.

Keywords: 1,2 epoxy-3-butene; 1,2:3,4-diepoxybutane; 1,3-butadiene; 1-hydroxy (or 2-hydroxy)-propyl-valine; 1-phenyl-2-hydroxyethyl-valine or 2-phenyl-2-hydroxyethyl-valine; 2,3,4-trihydroxybutyl-valine; 3,4-epoxy-1,2-butanediol; BD; Biomarkers; Biomonitoring; DEB; EB; EB-diol; ENU; ENU-Val; Et-Val; FA; H(2)N-Val; HB-Val; HP-Val; Hb; IA; LC–MS/MS; MMS; Me-Val; Mixtures; Multiple exposure detection; N,N-(2,3-dihydroxy-1,4-butadiyl)-valine; N-(2-hydroxy-3-buten-1-yl)-valine; N-ethyl-N-nitrosourea; N-terminal valine adducts; PO; SO; SO-Val; THB-Val; carbamoylated-valine; ethyl-valine; formic acid; hemoglobin; immunoaffinity; liquid chromatography–tandem mass spectrometry; methyl-methanesulfonate; methyl-valine; non-alkylated-valine; propylene oxide; pyr-Val; styrene oxide.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scheme of adduct profiling assay. The alkylated N-terminal peptides of the α-chain are isolated from trypsin hydrolyzed globin by series of depletion and selection IA chromatography, prior to analysis by LC-MS/MS as described in Materials and Methods.
Figure 2
Figure 2
Overview of selected model compounds and their corresponding N-terminal valine adducts.
Figure 3
Figure 3
Characterization of mouse SO-Val (1-11) standard. Mouse 1-11 peptide standard was reacted with SO in 0.1 M NH4HCO3 at pH 6.5 for 72 h. MS/MS fragmentation suggests single alkylation at the N-terminal valine.
Figure 4
Figure 4
Extracted ion chromatograms of mouse globin treated in vitro with a mixture of EB, DEB, PO and SO, MMS and ENU. The treated globin was processed as described in Materials and Methods and analyzed by LC-MS/MS. [13C5]SO-Val was utilized as internal standard.
Figure 5
Figure 5
Representative extracted ion-chromatogram of exposed mouse globin. B6C3F1 mice were treated with EB, SO, MMS and ENU and globin was isolated and analyzed as described in Materials and Methods. [13C5]SO-Val was utilized as internal standard.
Figure 6
Figure 6
Proposed formation of the ENU-derived carbamoyl adduct (ENU-Val).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Basile A, Ferranti P, Mamone G, Manco I, Pocsfalvi G, Malorni A, Acampora A, Sannolo N. Structural analysis of styrene oxide/haemoglobin adducts by mass spectrometry: identification of suitable biomarkers for human exposure evaluation. Rapid Commun. Mass Spectrom. 2002;16(9):871–878. - PubMed
    1. Basile A, Ferranti P, Pocsfalvi G, Mamone G, Miraglia N, Caira S, Ambrosi L, Soleo L, Sannolo N, Malorni A. A novel approach for identification and measurement of hemoglobin adducts with 1,2,3,4-diepoxybutane by liquid chromatography/electrospray ionisation mass spectrometry and matrix-assisted laser desorption/ionisation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2001;15(8):527–540. - PubMed
    1. Boysen G, Georgieva NI, Bordeerat NK, Sram RJ, Vacek P, Albertini RJ, Swenberg JA. Formation of 1,2:3,4-diepoxybutane-specific hemoglobin adducts in 1,3-butadiene exposed workers. Toxicol. Sci. 2012;125(1):30–40. - PMC - PubMed
    1. Boysen G, Georgieva NI, Upton PB, Walker VE, Swenberg JA. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides. Chem Biol Interact. 2007;166(1-3):84–92. - PubMed
    1. Boysen G, Georgieva NI, Upton PB, Jayaraj K, Li Y, Walker VE, Swenberg JA. Analysis of diepoxide-specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene. Cancer Res. 2004;64(23):8517–8520. - PubMed

Publication types